Archives

• Published on 22 Sept 2025

  HUG climbs sharply in Newsweek's 2026 global rankings

  

• Published on 18 Sept 2025

  Switzerland Launches National AI Initiative for Personalized Cancer Care

  

• Published on 18 Sept 2025

  Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

  

• Published on 10 Sept 2025

  Blood cancers: predicting the success of cell transplants

  

• Published on 4 Sept 2025

  Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer

  

• Published on 4 Sept 2025

  Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation

  

• Published on 2 Sept 2025

  Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX‑ONCO‑1, a novel, first in class cell encapsulation‑based immunotherapy: results of SAKK 11/16, a phase IIa trial